HCAL
NKTR icon

HURRICANE CAPITAL ADVISORS LLC’s Nektar Therapeutics NKTR Stock Holding History

HURRICANE CAPITAL ADVISORS LLC’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$628K Buy
9,000
+3,000
+50% +$220K 0.15% 130
2026
Q1 		$432K Sell
6,000
-9,000
-60% -$512K 0.13% 132
2025
Q4 		$634K Buy
15,000
+5,000
+50% +$280K 0.2% 85
2025
Q3 		$569K Buy
10,000
+7,500
+300% +$248K 0.14% 130
2025
Q2 		$64.6K Sell
2,500
-833
-25% -$9.35K 0.02% 423
2025
Q1 		$34K Buy
+3,333
New +$43.5K 0.01% 386

Other funds holding NKTR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Two Seas Capital
Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BVF Inc
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vestal Point Capital
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HURRICANE CAPITAL ADVISORS LLC's NKTR Position: Q2 2026 in Review

HURRICANE CAPITAL ADVISORS LLC increased its Nektar Therapeutics (NKTR) stake by 50% in Q2 2026, buying an estimated $220K and bringing the position to 9,000 shares worth $628K. The position accounts for 0.15% of the portfolio, ranked #130.

HURRICANE CAPITAL ADVISORS LLC first reported a position in NKTR in Q1 2025 and has held it in 6 quarters since. The position peaked at $634K in Q4 2025. 242 funds tracked by Wall St. Rank hold NKTR as of Q2 2026.

  • HURRICANE CAPITAL ADVISORS LLC held 9,000 shares of Nektar Therapeutics worth $628K as of Q2 2026.
  • HURRICANE CAPITAL ADVISORS LLC bought 3,000 Nektar Therapeutics shares in Q2 2026, an estimated $220K.
  • Nektar Therapeutics made up 0.15% of HURRICANE CAPITAL ADVISORS LLC's portfolio in Q2 2026, its #130 holding.
  • HURRICANE CAPITAL ADVISORS LLC first reported a position in Nektar Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • HURRICANE CAPITAL ADVISORS LLC's Nektar Therapeutics position peaked at $634K in Q4 2025.
  • 242 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q2 2026.

Based on HURRICANE CAPITAL ADVISORS LLC's 13F filing for Q2 2026, filed 3 Nov 2026.